EMA grants AR-501 with Orphan Drug Designation
Orphan Drug Designation has been given to AR-501 for the…
Orphan Drug Designation has been given to AR-501 for the treatment of lung infection in patients with cystic fibrosis.
List view / Grid view
Orphan Drug Designation has been given to AR-501 for the…
Orphan Drug Designation has been given to AR-501 for the treatment of lung infection in patients with cystic fibrosis.